1
UPPER MACUNGIE, PA. — Indianapolis-based pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has broken ground on a $3.5 billion manufacturing facility in the Lehigh Valley community of Upper Macungie. The development, which will support production of injectable medicines and other medical devices, will span about 925,000 square feet across multiple buildings. The project is expected to bring about 850 new jobs to the region and to create about 2,000 new construction jobs. Lilly acquired the site at 9802 Main St., which according to local news outlet WFMZ is known as Fogelsville Corporate Center, from Jaindl Land Development earlier this year.